Alves de Lima E Silva A, Rio-Tinto A
Interdiscip Perspect Infect Dis. 2024; 2024:9109041.
PMID: 38586592
PMC: 10998725.
DOI: 10.1155/2024/9109041.
Hoque E, Tran P, Jacobo U, Bergfeld N, Acharya S, Shamshina J
Molecules. 2023; 28(17).
PMID: 37687210
PMC: 10490204.
DOI: 10.3390/molecules28176381.
Maslanka M, Mucha A
Int J Mol Sci. 2023; 24(2).
PMID: 36675123
PMC: 9864093.
DOI: 10.3390/ijms24021610.
Guo Y, Ding S
Gastroenterol Res Pract. 2022; 2022:3175935.
PMID: 35958524
PMC: 9359846.
DOI: 10.1155/2022/3175935.
Adimulam T, Arumugam T, Foolchand A, Ghazi T, Chuturgoon A
Int J Mol Sci. 2021; 22(23).
PMID: 34884764
PMC: 8657714.
DOI: 10.3390/ijms222312952.
Stability of Antimicrobial Drug Molecules in Different Gravitational and Radiation Conditions in View of Applications during Outer Space Missions.
Simon A, Smarandache A, Iancu V, Pascu M
Molecules. 2021; 26(8).
PMID: 33921448
PMC: 8069917.
DOI: 10.3390/molecules26082221.
Evaluation of ebselen in resolving a methicillin-resistant Staphylococcus aureus infection of pressure ulcers in obese and diabetic mice.
Mohammad H, Abutaleb N, Dieterly A, Lyle L, Seleem M
PLoS One. 2021; 16(2):e0247508.
PMID: 33617589
PMC: 7899319.
DOI: 10.1371/journal.pone.0247508.
Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity.
Jaromin A, Zarnowski R, Pietka-Ottlik M, Andes D, Gubernator J
Nanomedicine (Lond). 2018; 13(10):1139-1155.
PMID: 29873597
PMC: 10334256.
DOI: 10.2217/nnm-2017-0337.
Synergistic antibacterial effect of silver and ebselen against multidrug-resistant Gram-negative bacterial infections.
Zou L, Lu J, Wang J, Ren X, Zhang L, Gao Y
EMBO Mol Med. 2017; 9(8):1165-1178.
PMID: 28606995
PMC: 5538294.
DOI: 10.15252/emmm.201707661.
Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells.
Thangamani S, Eldesouky H, Mohammad H, Pascuzzi P, Avramova L, Hazbun T
Biochim Biophys Acta Gen Subj. 2016; 1861(1 Pt A):3002-3010.
PMID: 27712973
PMC: 5148707.
DOI: 10.1016/j.bbagen.2016.09.029.
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
Ngo H, Shrestha S, Green K, Garneau-Tsodikova S
Bioorg Med Chem. 2016; 24(24):6298-6306.
PMID: 27073054
PMC: 5045767.
DOI: 10.1016/j.bmc.2016.03.060.
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens.
Thangamani S, Younis W, Seleem M
PLoS One. 2015; 10(7):e0133877.
PMID: 26222252
PMC: 4519285.
DOI: 10.1371/journal.pone.0133877.
Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections.
Thangamani S, Younis W, Seleem M
Sci Rep. 2015; 5:11596.
PMID: 26111644
PMC: 4481386.
DOI: 10.1038/srep11596.
Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections.
Younis W, Thangamani S, Seleem M
Curr Pharm Des. 2015; 21(28):4106-11.
PMID: 25961308
PMC: 4686870.
DOI: 10.2174/1381612821666150506154434.
Drug repurposing for the treatment of staphylococcal infections.
Thangamani S, Mohammad H, Younis W, Seleem M
Curr Pharm Des. 2015; 21(16):2089-100.
PMID: 25760334
PMC: 8672279.
DOI: 10.2174/1381612821666150310104416.
Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei.
Lu J, Vodnala S, Gustavsson A, Gustafsson T, Sjoberg B, Johansson H
J Biol Chem. 2013; 288(38):27456-27468.
PMID: 23900839
PMC: 3779740.
DOI: 10.1074/jbc.M113.495101.